Legend Biotech Corporation (LEGN) Stock Overview
Explore Legend Biotech Corporation’s financial performance, market position, analyst ratings, and future outlook.
Legend Biotech Corporation (LEGN)
Key Financials
Key Financials
Market Cap
5.5B
P/E Ratio
-21.99
EPS (TTM)
$-0.68
ROE
-0.25%
LEGN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Legend Biotech Corporation (LEGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 49.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $8.58.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -21.99 and a market capitalization of 5.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.